about
Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder.Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential.Resting-State Neuroimaging and Neuropsychological Findings in Opioid Use Disorder during Abstinence: A Review.Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.Indications for Opioid Antagonists.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoNovel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case study.The challenge of perioperative pain management in opioid-tolerant patients.Quantifying absolute glutamate concentrations in nucleus accumbens of prescription opioid addicts by using 1H MRS.Why aren't physicians prescribing more buprenorphine?Acute Myocardial Infarction following Naltrexone Consumption; a Case Report.Opioid agonist therapy.Opiates and Plasticity in the Ventral Tegmental Area.Opioid tapering in patients with prescription opioid use disorder: A retrospective study.Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?Addressing the prescription opioid crisis: Potential for hospital-based interventions?Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study.Treatment of opioid dependence with buprenorphine: current update.Buprenorphine Depresses Respiratory Variability in Obese Mice with Altered Leptin Signaling.Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol.Individual Placement and Support (IPS) for Methadone Maintenance Therapy Patients: A Pilot Randomized Controlled Trial.Extended-release injectable naltrexone for opioid use disorder: A systematic review.Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder.Opioid Prescribing: What Are the Numbers?Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach.Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.Evaluation of the Incidence of Ibuprofen Administration in Alcohol and Opioid Detoxification Patients With Concomitant Thrombocytopenia.Management of patients with pain and severe side effects while on intrathecal morphine therapy: A case study.Towards an Effective Peripheral Visceral Analgesic: Responding to the National Opioid Crisis.Coverage of Medications That Treat Opioid Use Disorder and Opioids for Pain Management in Marketplace Plans, 2017.Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients.Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy.Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphineNational trends and characteristics of inpatient detoxification for drug use disorders in the United StatesDelay-Dependent Impairments in Memory and Motor Functions After Acute Methadone Overdose in RatsEmerging Evidence for Cannabis' Role in Opioid Use Disorder
P2860
Q33629068-880285F6-E413-4E86-B19C-ADB403C38832Q34556427-3273A559-D8D9-4F77-9178-CAB5D579078DQ36352888-1D33AFB1-8C81-40B1-87D7-2DC1ACF23894Q38761584-556BCE83-75F5-4CB7-8AA9-7BCB9E94F892Q38762441-FAF25E6B-7674-417D-A30B-2622D3E871C9Q39359619-2524845E-9F74-4A1F-9288-58C9EE9EA752Q40081065-42170031-C7F6-4726-931E-0428166776CCQ41382878-6D6CA1D0-F63A-4AA3-A64A-EBA94F35DEC8Q41449171-CEC2D59C-9933-4D0C-9383-B9994E2C6BF1Q42024652-E40779A3-D1E6-4258-930B-46DCF1E02B51Q42183983-A4CD9D56-4D2D-4794-97E8-CFA3005563A0Q42333024-C0824107-2CA8-470E-931D-B61D8C95F220Q43061639-8C53BB1E-4DAE-4706-ABCC-F6092C49EFC4Q43075863-A94D0C15-9FDB-4B23-A1B9-DC962309F002Q44343590-F20925BE-11AC-450B-8453-762A5BB75C4CQ44344191-02771C69-0E34-463C-86D6-C21EF19F8C74Q44349155-5CACC483-0DFE-47F8-ABED-6AAB2220BBADQ44351006-87F2D332-1A84-46A4-ADA3-62E51CFEA8C5Q47133543-E4FCE418-5868-4CCE-8C68-07F69C2AA889Q47546989-E4082B81-B666-4457-ABB6-BC014795B7C9Q47712857-0C08DC7B-0D88-4CDF-8FDF-3DEB001FBEDCQ47796661-A4615195-FA0D-444C-932A-3223FB40BC02Q48111086-E71DA901-D158-4E64-8CC5-1E9FE8533C09Q48305244-70339AB5-58DE-4E68-B6B3-1E495691B928Q49583253-539D7A6D-1CE6-4674-B5BA-B0B77F5E26FDQ49953616-496D2666-2FA3-43AB-854D-FE36263DDF94Q50027846-DE64E750-8A3B-4A12-9B04-989A895E962AQ50055026-28B15C6A-D503-4EFC-86DA-7151FE9A6204Q50284026-C533C263-D999-4AFF-BB49-9BD45241097CQ52315691-E9DABD52-DF64-4B7B-B33E-F2C501E689D6Q52317985-6C5B07B4-194A-4D6F-8EF4-00143518D536Q55016401-C932B2CB-5DB5-4518-BB81-0C4D3B33DB1AQ55199602-BFF67548-2994-4854-A646-9C8C11015DC5Q55379537-E89B4CEB-FB0D-4A42-B0AD-AEB8F16734CBQ57816035-140B9BC2-FBEA-4CC7-89DB-33444019695DQ58696807-34ADFEFC-01E4-4845-A880-A77CA68418ACQ58754221-985375FA-F0BB-426F-85C2-B29EF6CD4064Q58775143-6006F7B2-33F1-429A-9C14-14BEEBB2C44F
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of Opioid-Use Disorders
@ast
Treatment of Opioid-Use Disorders
@en
Treatment of Opioid-Use Disorders
@nl
type
label
Treatment of Opioid-Use Disorders
@ast
Treatment of Opioid-Use Disorders
@en
Treatment of Opioid-Use Disorders
@nl
prefLabel
Treatment of Opioid-Use Disorders
@ast
Treatment of Opioid-Use Disorders
@en
Treatment of Opioid-Use Disorders
@nl
P356
P1476
Treatment of Opioid-Use Disorders
@en
P304
P356
10.1056/NEJMRA1604339
P407
P577
2016-07-28T00:00:00Z